Incyte (INCY) Misses Q2 EPS by 3c, Sales Beat; Raises FY17 Jakafi Revenue Outlook
Go back to Incyte (INCY) Misses Q2 EPS by 3c, Sales Beat; Raises FY17 Jakafi Revenue Outlook| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 124.44 -0.21 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.65 | 52 Week High | $118.49 | |||
| Open | $124.72 | 52 Week Low | $55.00 | |||
| Day High | $125.33 | P/E | N/A | |||
| Day Low | $124.01 | EPS | $-0.56 | |||
| Volume | 55,528 | |||||
